Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies

Adamson, 2016, A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response, Cell, 167, 1867, 10.1016/j.cell.2016.11.048 Anderson, 2017, Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies, Cancer Cell, 31, 311, 10.1016/j.ccell.2017.02.008 Arber, 2017, Reprogramming cellular functions with engineered membrane proteins, Curr. Opin. Biotechnol., 47, 92, 10.1016/j.copbio.2017.06.009 Batlle, 2019, Transforming Growth Factor-β Signaling in Immunity and Cancer, Immunity, 50, 924, 10.1016/j.immuni.2019.03.024 Binnewies, 2018, Understanding the tumor immune microenvironment (TIME) for effective therapy, Nat. Med., 24, 541, 10.1038/s41591-018-0014-x Butler, 2018, Integrating single-cell transcriptomic data across different conditions, technologies, and species, Nat. Biotechnol., 36, 411, 10.1038/nbt.4096 Cavazzana-Calvo, 2010, Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia, Nature, 467, 318, 10.1038/nature09328 Chavez, 2015, Highly efficient Cas9-mediated transcriptional programming, Nat. Methods, 12, 326, 10.1038/nmeth.3312 Chen, 2013, Oncology meets immunology: the cancer-immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012 Chen, 2016, CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy, Oncoimmunology, 6, e1273302, 10.1080/2162402X.2016.1273302 Dahmani, 2018, TGF-β in T cell biology: Implications for cancer immunotherapy, Cancers (Basel), 10, E194, 10.3390/cancers10060194 Datlinger, 2017, Pooled CRISPR screening with single-cell transcriptome readout, Nat. Methods, 14, 297, 10.1038/nmeth.4177 Dixit, 2016, Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens, Cell, 167, 1853, 10.1016/j.cell.2016.11.038 Dong, 2019, Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells, Cell, 178, 1189, 10.1016/j.cell.2019.07.044 Esensten, 2017, Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials, Annu. Rev. Pathol., 12, 305, 10.1146/annurev-pathol-052016-100304 Eyquem, 2017, Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection, Nature, 543, 113, 10.1038/nature21405 Fabregat, 2018, The Reactome Pathway Knowledgebase, Nucleic Acids Res., 46, D649, 10.1093/nar/gkx1132 Feldman, 2018, Lentiviral co-packaging mitigates the effects of intermolecular recombination and multiple integrations in pooled genetic screens, bioRxiv Fesnak, 2016, Engineered T cells: the promise and challenges of cancer immunotherapy, Nat. Rev. Cancer, 16, 566, 10.1038/nrc.2016.97 Findlay, 2014, Saturation Editing of Genomic Regions by Multiplex Homology-Directed Repair, Nature, 513, 120, 10.1038/nature13695 Findlay, 2018, Accurate Classification of BRCA1 Variants With Saturation Genome Editing, Nature, 562, 217, 10.1038/s41586-018-0461-z Fischbach, 2013, Cell-based therapeutics: the next pillar of medicine, Sci. Transl. Med., 5, 179ps7, 10.1126/scitranslmed.3005568 Gigante, 2012, TGF-beta: a master switch in tumor immunity, Curr. Pharm. Des., 18, 4126, 10.2174/138161212802430378 Gilbert, 2013, CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes, Cell, 154, 442, 10.1016/j.cell.2013.06.044 Gilbert, 2014, Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation, Cell, 159, 647, 10.1016/j.cell.2014.09.029 Gorelik, 2000, Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease, Immunity, 12, 171, 10.1016/S1074-7613(00)80170-3 Gwiazda, 2016, High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k “Helper” Proteins, Mol. Ther., 24, 1570, 10.1038/mt.2016.105 Hanna, 2018, A case of mistaken identity, Nat. Biotechnol., 36, 802, 10.1038/nbt.4208 Hegde, 2018, Uncoupling of sgRNAs from their associated barcodes during PCR amplification of combinatorial CRISPR screens, PLoS ONE, 13, e0197547, 10.1371/journal.pone.0197547 Hess, 2016, Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells, Nat. Methods, 13, 1036, 10.1038/nmeth.4038 Jaitin, 2016, Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq, Cell, 167, 1883, 10.1016/j.cell.2016.11.039 June, 2018, Chimeric Antigen Receptor Therapy, N. Engl. J. Med., 379, 64, 10.1056/NEJMra1706169 Khan, 2019, TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion, Nature, 571, 211, 10.1038/s41586-019-1325-x Kim, 2017, An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling, J. Biol. Chem., 292, 7173, 10.1074/jbc.M116.768754 Kloss, 2018, Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication, Mol. Ther., 26, 1855, 10.1016/j.ymthe.2018.05.003 Kurtulus, 2019, Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells, Immunity, 50, 181, 10.1016/j.immuni.2018.11.014 Leen, 2014, Reversal of tumor immune inhibition using a chimeric cytokine receptor, Mol. Ther., 22, 1211, 10.1038/mt.2014.47 Liu, 2016, A chimeric switch-receptor targeting PD1 augments the efficacy of second-generation CAR T cells in advanced solid tumors, Cancer Res., 76, 1578, 10.1158/0008-5472.CAN-15-2524 Lynn, 2019, c-Jun overexpression in CAR T cells induces exhaustion resistance, Nature, 576, 293, 10.1038/s41586-019-1805-z Ma, 2016, Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells, Nat. Methods, 13, 1029, 10.1038/nmeth.4027 Morgan, 2009, ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data, Bioinformatics, 25, 2607, 10.1093/bioinformatics/btp450 Nguyen, 2020, A Cas9 nanoparticle system with truncated Cas9 target sequences on DNA repair templates enhances genome targeting in diverse human immune cell types, Nature Biotechnology Oda, 2017, A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia, Blood, 130, 2410, 10.1182/blood-2017-04-777052 Ostrand-Rosenberg, 2012, Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression, Semin. Cancer Biol., 22, 275, 10.1016/j.semcancer.2012.01.011 Paquet, 2016, Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9, Nature, 533, 125, 10.1038/nature17664 Prosser, 2012, Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor, Mol. Immunol., 51, 263, 10.1016/j.molimm.2012.03.023 Rafiq, 2020, Engineering strategies to overcome the current roadblocks in CAR T cell therapy, Nat. Rev. Clin. Oncol., 17, 147, 10.1038/s41571-019-0297-y Ren, 2017, Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition, Clin. Cancer Res., 23, 2255, 10.1158/1078-0432.CCR-16-1300 Romero, 2013, β-globin gene transfer to human bone marrow for sickle cell disease, J. Clin. Invest., 67930 Roth, 2018, Reprogramming human T cell function and specificity with non-viral genome targeting, Nature, 559, 405, 10.1038/s41586-018-0326-5 Rupp, 2017, CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells, Sci. Rep., 7, 737, 10.1038/s41598-017-00462-8 Sack, 2016, Sources of error in mammalian genetic screens, G3 (Bethesda), 6, 2781, 10.1534/g3.116.030973 Sadelain, 2017, Therapeutic T cell engineering, Nature, 545, 423, 10.1038/nature22395 Sanjana, 2017, Genome-scale CRISPR pooled screens, Anal. Biochem., 532, 95, 10.1016/j.ab.2016.05.014 Sergushichev, 2016, An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation, bioRxiv Shalem, 2014, Genome-scale CRISPR-Cas9 Knockout Screening in Human Cells, Science, 343, 84, 10.1126/science.1247005 Shifrut, 2018, Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function, Cell, 175, 1958, 10.1016/j.cell.2018.10.024 Shin, 2012, Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models, Blood, 119, 5678, 10.1182/blood-2011-09-380519 Shin, 2016, Enhanced anti-tumor reactivity of cytotoxic T lymphocytes expressing PD-1 decoy, Immune Netw., 16, 134, 10.4110/in.2016.16.2.134 Siddiqui, 2019, Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy, Immunity, 50, 195, 10.1016/j.immuni.2018.12.021 Stadtmauer, 2020, CRISPR-engineered T cells in patients with refractory cancer, Science, 367, 80, 10.1126/science.aba7365 Strasser, 2009, The many roles of FAS receptor signaling in the immune system, Immunity, 30, 180, 10.1016/j.immuni.2009.01.001 Su, 2016, CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients, Sci. Rep., 6, 20070, 10.1038/srep20070 Tay, 2017, Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers, Immunotherapy, 9, 1339, 10.2217/imt-2017-0103 Thomas, 2005, TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance, Cancer Cell, 8, 369, 10.1016/j.ccr.2005.10.012 Wang, 2014, Genetic Screens in Human Cells Using the CRISPR-Cas9 System, Science, 343, 80, 10.1126/science.1246981 Wei, 2019, Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy, Nature, 576, 471, 10.1038/s41586-019-1821-z Weiner, 2010, Monoclonal antibodies: versatile platforms for cancer immunotherapy, Nat. Rev. Immunol., 10, 317, 10.1038/nri2744 Wherry, 2011, T cell exhaustion, Nat. Immunol., 12, 492, 10.1038/ni.2035 Wu, 2016, The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness, Sci. Immunol., 1, eaai8593, 10.1126/sciimmunol.aai8593 Yamamoto, 2019, T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy, J. Clin. Invest., 129, 1551, 10.1172/JCI121491 Zaretsky, 2016, Mutations Associated With Acquired Resistance to PD-1 Blockade in Melanoma, N. Engl. J. Med., 375, 819, 10.1056/NEJMoa1604958 Zheng, 2017, Massively parallel digital transcriptional profiling of single cells, Nat. Commun., 8, 14049, 10.1038/ncomms14049